Lupin obtains tentative nod for vaccine to cure toenail fungal infection disease
Lupin obtains tentative nod for vaccine to cure toenail fungal infection disease

Lupin obtains tentative nod for vaccine to cure toenail fungal infection disease

Shreya Chaware Article rating: 2.7

Lupin Limited informed that it has received tentative approval from United States Food & Drug Administration for Efinaconazole topical solution, 10 per cent to market a generic equivalent of Jublia® topical solution, 10 per cent of Bausch Health Americas, Inc. This solution is used to cure Onychomycosis, a fungal infection caused in nails. 

DLF shares surge 4 per cent on plans of acquiring majority stake in Fairleaf
DLF shares surge 4 per cent on plans of acquiring majority stake in Fairleaf

DLF shares surge 4 per cent on plans of acquiring majority stake in Fairleaf

Anthony Fernandes Article rating: 4.1

The shares of India’s leading real estate developer, DLF Limited, were up by more than 4 per cent during the early trade on Monday after the company revealed its plans to acquire a 51.8 per cent stake in Fairleaf, a joint venture company, which owns and operates One Horizon Center in Gurugram.  

Advanced Enzymes Tech buys 51 per cent stake in SciTech Specialities
Advanced Enzymes Tech buys 51 per cent stake in SciTech Specialities

Advanced Enzymes Tech buys 51 per cent stake in SciTech Specialities

Apurva Joshi Article rating: 4.2

Advanced Enzymes Technologies Limited’s (AETL) board of directors have approved the issuance of 4,92,630 equity shares of SciTech Specialities Private Limited (SSPL) to be offered on a preferential issue/private placement basis by SSPL. It also includes the purchase of 27,778 equity shares from selling shareholders of SSPL, aggregating to 5,20,408 equity shares i.e. 51 per cent of the equity share capital of SSPL.

Why you must read KIM, SAI & SID
Why you must read KIM, SAI & SID

Why you must read KIM, SAI & SID

Shashikant Singh Article rating: 3.3

Reading these documents would help you to understand the basic facts that are important for making an investment decision on any fund.

Worries about COVID strain recede post AstraZeneca Chief claims of vaccine effectiveness
Worries about COVID strain recede post AstraZeneca Chief claims of vaccine effectiveness

Worries about COVID strain recede post AstraZeneca Chief claims of vaccine effectiveness

Karan Dsij Article rating: 5.0

After rallying 17 per cent in the previous seven consecutive weeks, the bulls hit a pause button amid the discovery of a new strain of Coronavirus in the UK. However, after an initial trauma, Nifty recovered smartly in the remaining part of the week and ended the week with modest losses of 0.08 per cent.

Stocks that are likely to record significant movement on bourses today
Stocks that are likely to record significant movement on bourses today

Stocks that are likely to record significant movement on bourses today

Karan Dsij Article rating: 5.0

Asian Granito: The company is eyeing exponential growth from the export business in the current fiscal. Anti-China sentiments, reduction in gas prices, and robust export orders from the USA, Europe, UK, and the Middle East are driving the export business in the current fiscal and it is expected to get further momentum in the coming months.

Nifty trend for Monday
Nifty trend for Monday

Nifty trend for Monday

Karan Dsij Article rating: 4.6

Every now and then, people talk about how mainstream window shopping has switched to online shopping and how the gentlemen’s game i.e. Cricket, shifted its gears from Test Cricket to the fast & furious mode i.e. T-20 Cricket.

Ambuja & ACC jump post renewal of tech fees with Holcim
Ambuja & ACC jump post renewal of tech fees with Holcim

Ambuja & ACC jump post renewal of tech fees with Holcim

Anthony Fernandes Article rating: 5.0

The shares of Holcim-promoted cement companies, Ambuja Cements & ACC Ltd were trading in the green on Thursday after the companies received board approval for paying technology fees to their parent company, Holcim Limited.  

RSS
First23132314231523162318232023212322Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR